Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Spironolactone may have prognostic benefit in selected patients with heart failure with preserved ejection fraction. This study assessed the myocardial tissue effects of spironolactone in heart failure with preserved ejection fraction. METHODS AND RESULTS: A 1:1 randomized controlled stu...

Descripción completa

Detalles Bibliográficos
Autores principales: McDiarmid, Adam K., Swoboda, Peter P., Erhayiem, Bara, Bounford, Katrina A., Bijsterveld, Petra, Tyndall, Keith, Fent, Graham J., Garg, Pankaj, Dobson, Laura E., Musa, Tarique A., Foley, James R. J., Witte, Klaus K., Kearney, Mark T., Greenwood, John P., Plein, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988171/
https://www.ncbi.nlm.nih.gov/pubmed/31852424
http://dx.doi.org/10.1161/JAHA.118.011521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988171/
https://www.ncbi.nlm.nih.gov/pubmed/31852424
http://dx.doi.org/10.1161/JAHA.118.011521

Ejemplares similares